En
Product Name | Specification | Approved | CAS No. |
Oxcarbazepine | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepine Acetate | In-house | DMF | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochloride | USP | DMF | 175865-59-5 |
Oseltamivir Phosphate | CP/EP/USP | DMF | 204255-11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF/FDA | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Product Name | CAS No. |
Neomycin Sulphate | 1405-10-3 |
Doxycycline Hychlate | 564-25-0 |
Oxytetracycline Hcl | 2058-46-0 |
Amoxicilin | 26787-78-0 |
Colistin Sulphate | 1264-72-8 |
Florfenicol | 73231-34-2 |
Erythromycin Thiocyanate | 7704-67-8 |
Oxytetracycline Base | 79-57-2 |
Product Name | Specification | CATEGORY | CAS No. |
Valacyclovir Hcl | CP/EP/USP/JP | Anti-Viral | 124832-27-5 |
Pefloxacin Mesylate | CP/EP | Antibacterial | 70458-95-6 |
PhenylPropanol | CP | Cholagogic | 93-54-9 |
Enoxacin Gluconate | IN HOUSE | Antibacterial | 74011-58-8 |
Levobupivacaine Hcl | IN HOUSE | Local Anesthetic | 27262-48-2 |
Ambrisentan | IN HOUSE | Pulmonary Hypertension | 177036-94-1 |
Solifenacin Succinate | IN HOUSE | Urinary Incontinence | 42478-38-2 |
Tadalafil | EP/USP | Male Erectile Dysfunction | 171596-29-5 |